• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Avery Therapeutics, Inc.

Monday, June 03, 2024
CP
Platform for Therapeutics
Avery Therapeutics is developing first-in-class immunomodulatory therapeutics to redirect the immune system to address diseases of aging, inflammation, and fibrosis. Avery's lead program is under development for heart failure, one of the leading causes of death in the world.
Avery Therapeutics, Inc.
Company Website: https://averythera.com
Lead Product in Development: Novel immunomodulatory platform

Company HQ City

Tucson

Company HQ State

AZ

Company HQ Country

United States

CEO/Top Company Official

Jordan Lancaster

Development Phase of Primary Product

Pre-Clinical
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS